López-Hernandez FJ - Search Results

1

Effects of deferasirox on renal function and renal epithelial cell death.

Sánchez-González PD, López-Hernandez FJ, Morales AI, Macías-Nuñez JF, López-Novoa JM. Sánchez-González PD, et al. Toxicol Lett. 2011 Jun 10;203(2):154-61. doi: 10.1016/j.toxlet.2011.03.018. Epub 2011 Mar 23. Toxicol Lett. 2011. PMID: 21439361

2

Antihypertensive action of trandolapril and verapamil in spontaneously hypertensive rats after unilateral nephrectomy.

López-Hernández FJ, Flores O, López-Novoa JM, Montero MJ, Carrón R. López-Hernández FJ, et al. J Cardiovasc Pharmacol. 1998 Aug;32(2):284-90. doi: 10.1097/00005344-199808000-00016. J Cardiovasc Pharmacol. 1998. PMID: 9700991

3

Antihypertensive effect of trandolapril and verapamil in rats with induced hypertension.

López-Hernández FJ, Carrón R, Montero MJ, Flores O, López-Novoa JM, Arévalo MA. López-Hernández FJ, et al. J Cardiovasc Pharmacol. 1999 May;33(5):748-55. doi: 10.1097/00005344-199905000-00011. J Cardiovasc Pharmacol. 1999. PMID: 10226862

4

The lord of the ring: mandatory role of the kidney in drug therapy of hypertension.

López-Hernández FJ, López-Novoa JM. López-Hernández FJ, et al. Pharmacol Ther. 2006 Jul;111(1):53-80. doi: 10.1016/j.pharmthera.2005.08.002. Epub 2005 Sep 8. Pharmacol Ther. 2006. PMID: 16154201 Review.

5

Glomerular nephrotoxicity of aminoglycosides.

Martínez-Salgado C, López-Hernández FJ, López-Novoa JM. Martínez-Salgado C, et al. Toxicol Appl Pharmacol. 2007 Aug 15;223(1):86-98. doi: 10.1016/j.taap.2007.05.004. Epub 2007 May 21. Toxicol Appl Pharmacol. 2007. PMID: 17602717 Review.

6

Potential utility of PPARalpha activation in the prevention of ischemic and drug-induced acute renal damage.

Lopez-Hernandez FJ, Lopez-Novoa JM. Lopez-Hernandez FJ, et al. Kidney Int. 2009 Nov;76(10):1022-4. doi: 10.1038/ki.2009.229. Kidney Int. 2009. PMID: 19876055 Free article.

7

An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease.

García-Sánchez O, López-Hernández FJ, López-Novoa JM. García-Sánchez O, et al. Kidney Int. 2010 Jun;77(11):950-5. doi: 10.1038/ki.2010.88. Epub 2010 Mar 24. Kidney Int. 2010. PMID: 20336053 Free article. Review.

8

Differential effects of 17beta-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency.

Naves-Díaz M, Carrillo-López N, Rodríguez-Rodríguez A, Braga S, Fernández-Coto T, Lopez-Novoa JM, López-Hernández F, Cannata-Andía JB. Naves-Díaz M, et al. Menopause. 2010 Jul;17(4):766-71. doi: 10.1097/gme.0b013e3181ce6874. Menopause. 2010. PMID: 20386345

9

Nephrotoxicity of uranium: pathophysiological, diagnostic and therapeutic perspectives.

Vicente-Vicente L, Quiros Y, Pérez-Barriocanal F, López-Novoa JM, López-Hernández FJ, Morales AI. Vicente-Vicente L, et al. Toxicol Sci. 2010 Dec;118(2):324-47. doi: 10.1093/toxsci/kfq178. Epub 2010 Jun 16. Toxicol Sci. 2010. PMID: 20554698 Review.

10

Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspectives.

López-Novoa JM, Martínez-Salgado C, Rodríguez-Peña AB, López-Hernández FJ. López-Novoa JM, et al. Pharmacol Ther. 2010 Oct;128(1):61-81. doi: 10.1016/j.pharmthera.2010.05.006. Epub 2010 Jun 19. Pharmacol Ther. 2010. PMID: 20600306 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters